Response to and Survival after First-Line FOLFIRINOX or Gemcitabine/Nab-Paclitaxel for Localized Pancreatic Ductal Adenocarcinoma

Published on Jan 1, 2021in Hpb3.401
· DOI :10.1016/J.HPB.2020.11.027
Giampaolo Perri9
Estimated H-index: 9
,
Laura P Prakash + 6 AuthorsM. Katz3
Estimated H-index: 3
Source
Abstract
References0
Newest
Cited By0
Newest